MAPKAPK-2

ANTIBODY polyclonal manufacturer Cat# IMG-90587-2 Immunogen = synthetic non- phosphopeptide corresp. to human MAPKAPK-2 around the phosphorylation site of threonine 334 (P-Q-TP-P-L) liquid, PBS, glycerol, azide,affinity purified MAPKAPK2 IgG MAPKs Imgenex Rabbit H

International Conference on Alzheimer's Disease 2008

CONFERENCE COVERAGE SERIES Chicago: Studies Probe Diminishing Placebo Decline, Part 1 Chicago: Studies Probe Diminishing Placebo Decline, Part 2 Chicago: ICAD Offered Mix Bag of Setbacks and Hopeful News Chicago: Trial Design Bedevils Search for New AD Drugs, Part 1 Chicago: The Ph

ERK /MAPK

ANTIBODY polyclonal manufacturer Cat# IMG-5099 immunogen = synthetic phosphor. peptide corresp. to amino acids 196-208 of human MAPK liquid, PBS, gelatin, azide, protein-G purified ERK/MAPK IgG MAPKs Imgenex Rabbit Bovine Frog Flounder Human Mouse Rat C. elegans D

ERK2/ MAPK1

ANTIBODY polyclonal manufacturer Cat# IMG-80473 immunogen = synthetic peptide derived from C-terminus of mouse ERK-2 protein liquid, purified Ig fraction, azide ERK2 /MAPK1 IgG MAPKs Imgenex Rabbit Mouse Rat ERK2/ MAPK1 http://alzforum.org/res/com/ant/default.asp?

ERK1/ MAPK3

ANTIBODY polyclonal manufacturer Cat# IMG-71995 immunogen = synthetic peptide corresp. to the internal domain of human ERK-1 protein liquid, PBS, azide, affinity purified ERK1 /MAPK3 IgG MAPKs Imgenex Rabbit Human ERK1/ MAPK3 http://alzforum.org/res/com/ant/defaul

ERK1/ MAPK3

ANTIBODY polyclonal manufacturer Cat# IMG-71973 immunogen = synthetic peptide corresp. to the internal domain of human ERK-1 protein liquid, PBS, azide, affinity purified ERK1 /MAPK3 IgG MAPKs Imgenex Rabbit Human ERK1/ MAPK3 http://alzforum.org/res/com/ant/defaul

ERK1/ MAPK3

ANTIBODY polyclonal manufacturer Cat# IMG-80472 immunogen = synthetic peptide derived from C-terminus of rat ERK-1 protein liquid, purified Ig fraction, azide ERK1 /MAPK3 IgG MAPKs Imgenex Rabbit Mouse Rat ERK1/ MAPK3 http://alzforum.org/res/com/ant/default.asp?an

Chicago: Flurizan Postmortem

CONFERENCE COVERAGE 2008-08-20 Conference Coverage At the International Conference for Alzheimer’s Disease, 26-31 July in Chicago, investigators reported results on a range of different clinical trials. There were no breakthroughs but the field is shifting. While some new drug candidat

PAPER Gonzalez-Romero D, Barria MA, Leon P, Morales R, Soto C

Detection of infectious prions in urine.

FEBS Lett. 2008 Sep 22;582(21-22):3161-6. Epub 2008 Aug 13 PubMed: 18706416

PAPER Teeling JL, Perry VH

Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms.

Neuroscience. 2009 Feb 6;158(3):1062-73. PubMed: 18706982

PAPER Hanstein R, Lu A, Wurst W, Holsboer F, Deussing JM, Clement AB, Behl C

Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress.

Neuroscience. 2008 Oct 15;156(3):712-21. PubMed: 18708129

PAPER Leandro P, Gomes CM

Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning.

Mini Rev Med Chem. 2008 Aug;8(9):901-11. PubMed: 18691147

PAPER Mancuso M, Kiferle L, Petrozzi L, Nesti C, Rocchi A, Ceravolo R, Orsucci D, Maluccio MR, Bonuccelli U, Filosto M, Siciliano G, Murri L

Mitochondrial DNA haplogroups do not influence the Huntington's disease phenotype.

Neurosci Lett. 2008 Oct 17;444(1):83-6. PubMed: 18706972

PAPER Gutierrez-Cuesta J, Tajes M, Jiménez A, Coto-Montes A, Camins A, Pallàs M

Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model.

J Pineal Res. 2008 Nov;45(4):497-505. PubMed: 18705649

Hongjun (Harry) Fu

The Ohio State University Wexner Medical Center
Columbus , United States